# Efficacy of Sirolimus In Liver Transplantation for Hepatocellular Carcinoma (HCC)

> **NCT01374750** · PHASE2 · COMPLETED · sponsor: **Seoul National University Hospital** · enrollment: 45 (actual)

## Conditions studied

- Hepatocellular Carcinoma

## Interventions

- **DRUG:** Sirolimus
- **DRUG:** m-TOR inhibitor free

## Key facts

- **NCT ID:** NCT01374750
- **Lead sponsor:** Seoul National University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-05
- **Primary completion:** 2016-05
- **Final completion:** 2016-05
- **Target enrollment:** 45 (ACTUAL)
- **Last updated:** 2016-06-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01374750

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01374750, "Efficacy of Sirolimus In Liver Transplantation for Hepatocellular Carcinoma (HCC)". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01374750. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*